Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness study

BMC Endocrine Disorders ◽

10.1186/s12902-016-0116-8 ◽

2016 ◽

Vol 16 (1) ◽

Author(s):

Amir Farshchi ◽

Rokhsareh Aghili ◽

Maryam Oskuee ◽

Marjan Rashed ◽

Sina Noshad ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Human Insulin ◽

Insulin Aspart ◽

Effectiveness Study ◽

Regular Human Insulin ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Cost Effectiveness Study

Download Full-text

PDB24 COST EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO BIPHASIC INSULIN ASPART 30 FROM BIPHASIC HUMAN INSULIN 30 IN THE CZECH SETTING

Value in Health ◽

10.1016/s1098-3015(10)75002-6 ◽

2009 ◽

Vol 12 (7) ◽

pp. A405-A406

Author(s):

E Suchankova ◽

T Doležal ◽

Z Pisarikova ◽

K Rychna ◽

D Bartaskova

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Human Insulin ◽

Insulin Aspart ◽

Cost Effectiveness Analysis ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Effectiveness Analysis ◽

Biphasic Insulin Aspart 30

Download Full-text

An analysis of the cost-effectiveness of switching from biphasic human insulin 30, insulin glargine, or neutral protamine Hagedorn to biphasic insulin aspart 30 in people with type 2 diabetes

Journal of Medical Economics ◽

10.3111/13696998.2014.991791 ◽

2015 ◽

Vol 18 (4) ◽

pp. 263-272 ◽

Author(s):

Vishal Gupta ◽

Ranya Baabbad ◽

Eva Hammerby ◽

Annie Nikolajsen ◽

Asrul Akmal Shafie

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Neutral Protamine Hagedorn ◽

Download Full-text

Cost-Effectiveness of Switching to Biphasic Insulin Aspart 30 from Human Insulin in Patients with Poorly Controlled Type 2 Diabetes in South Korea

Value in Health ◽

10.1111/j.1524-4733.2009.00628.x ◽

2009 ◽

Vol 12 ◽

pp. S55-S61 ◽

Author(s):

Kyoung Hee Lee ◽

Se Jin Seo ◽

Jayne Smith-Palmer ◽

James L. Palmer ◽

Jeremy White ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

South Korea ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30

Download Full-text

Short And Long-Term Cost-Effectiveness Of Switching Therapy From Biphasic Human Insulin 30 To Biphasic Insulin Aspart 30 In People With Type-2 Diabetes

Value in Health ◽

10.1016/j.jval.2013.03.819 ◽

2013 ◽

Vol 16 (3) ◽

pp. A164

Author(s):

P.D. Home ◽

P. Soewondo ◽

Z. Hussein ◽

A.A. Shafie ◽

K. AlRaddady ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Switching Therapy ◽

Short And Long Term

Download Full-text

DB1 PROJECTED COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 IN TYPE 2 DIABETES PATIENTS SWITCHED FROM BIPHASIC HUMAN INSULIN IN THE UNITED STATES

Value in Health ◽

10.1016/s1098-3015(10)73111-9 ◽

2009 ◽

Vol 12 (3) ◽

pp. A10 ◽

Author(s):

M Aagren ◽

TL Thomsen ◽

VK Knudsen

Keyword(s):

United States ◽

Type 2 Diabetes ◽

Cost Effectiveness ◽

Human Insulin ◽

Insulin Aspart ◽

The United States ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30

Download Full-text

PDB5 GLYCAEMIC CONTROL AND INSULIN UTILIZATION IN UK PATIENTS WITH TYPE 2 DIABETES INITIATED ON EITHER BIPHASIC INSULIN ASPART 30 OR BIPHASIC HUMAN INSULIN 30

Value in Health ◽

10.1016/s1098-3015(10)72252-x ◽

2010 ◽

Vol 13 (3) ◽

pp. A55 ◽

Author(s):

W Fakhoury ◽

H Richter ◽

T Christensen ◽

TL Thomsen ◽

D Irwin ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30

Download Full-text

A double-blind, randomised, crossover study to investigate the difference in frequency of episodes of hypoglycaemia during treatment with Biphasic Insulin Aspart 30 (NovoMix®30) compared to Biphasic Human Insulin 30 (Mixtard® 30) in patients with well-controlled, type 2 diabetes

http://isrctn.org/> ◽

10.1186/isrctn34091554 ◽

2013 ◽

Author(s):

Paul McNally

Keyword(s):

Type 2 Diabetes ◽

Crossover Study ◽

Human Insulin ◽

Insulin Aspart ◽

Double Blind ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Download Full-text

DB1 EVALUATING THE COST-EFFECTIVENESS OF THERAPY CONVERSION FROM BASAL INSULIN TO BIPHASIC INSULIN ASPART 30/70 IN PATIENTS WITH TYPE 2 DIABETES IN CHINA: A MODELING STUDY OF LONG-TERM COSTS AND HEALTH OUTCOMES

Value in Health ◽

10.1016/s1098-3015(11)73078-9 ◽

2010 ◽

Vol 13 (7) ◽

pp. A507

Author(s):

J Chang ◽

F Sun ◽

H Li

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Health Outcomes ◽

Insulin Aspart ◽

Basal Insulin ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Download Full-text

Safety and efficacy of biphasic insulin aspart 30 in type 2 diabetes patients switched from either biphasic or basal human insulin: results from the Gulf cohort of the A1chieve study

International Journal of Clinical Practice ◽

10.1111/ijcp.12391 ◽

2014 ◽

Vol 68 (7) ◽

pp. 850-856 ◽

Author(s):

A. Almansari ◽

S. Khader ◽

A. Kharawagh ◽

W. AbdelFattah ◽

T. Badawy

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Insulin Aspart ◽

Safety And Efficacy ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Diabetes Patients

Download Full-text

Clinical experience of switching from biphasic human insulin to biphasic insulin aspart 30 in Indian patients with type 2 diabetes in the A1chieve study

Indian Journal of Endocrinology and Metabolism ◽

10.4103/2230-8210.131759 ◽

2015 ◽

Vol 19 (1) ◽

pp. 110 ◽

Author(s):

Shahid Akhtar ◽

Raman Shetty ◽

Ajay Kumar ◽

AK Das ◽

Sanjay Kalra

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Clinical Experience ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Indian Patients ◽

Biphasic Insulin Aspart 30

Download Full-text